Amplifon stands out in the 2022 Institutional Investor's Ranking

Share on
Last updated on September 13, 2022 at 08:00 pm
  • Amplifon ranked first in Europe for "Best Company in Investor Relations - Pharmaceutical & Healthcare" and for the Grand Prix "Best Overall Company in IR" among Mid & Small Cap companies
  • Important awards also for the CEO, Enrico Vita, for the CFO, Gabriele Galli, and the Investor Relations & Sustainability Sr director, Francesca Rambaudi

Amplifon S.p.A. (MTA; Bloomberg ticker: AMP:IM), the global leader in hearing solutions and services, was also included in the 2022 edition of the prestigious "All-Europe Executive Team" ranking by Institutional Investor, an independent research institute in international finance.

Amplifon was ranked first in the "Best Company in Investor Relations - Pharmaceutical & Healthcare" category and for the Grand Prix, "Best Overall Company in IR."

In addition, at the individual level, Institutional Investor awarded the CEO of Amplifon, Enrico Vita, for the Medical Technologies & Services sector overall, in first place in the "Best CEO" category. The CFO, Gabriele Galli, is in second place in the "Best CFO" category; and Francesca Rambaudi, Investor Relations & Sustainability Sr Director, gained second place in the "Best IR Professionals" category.

The ranking, which reflects the ratings of more than 1,380 professionals, financial analysts and institutional investors representing more than 600 financial services companies, attests to the international community's appreciation for the dialogue and trusting relationship the Group has established with the financial market over the years.

Save your copy

Please think about the environment before printing

Type: PDF
Size: 0.2 MB
page 37 of 37

Keep in touch

Do you want to talk to us?

Write an e-mail to our team.

Contact us

Are you keen on our news?

Subscribe to our newsletter.


true and false